Printer Friendly

Key protein behind pulmonary arterial hypertension identified.

Byline: ANI

London, Oct 26 (ANI): In a groundbreaking discovery, researchers at the University of California, San Diego, have identified a key protein that promotes the development of pulmonary arterial hypertension in humans and mice.

The finding has implications for future drug therapies that may extend the life of patients with pulmonary arterial hypertension and prevent the need for lung transplantation, currently the only cure for this debilitating disease.

In the study, Dr. Patricia Thistlethwaite and colleagues have described the genetic pathway by which vascular smooth muscle cells linked with pulmonary arterial hypertension are switched on to proliferate by a receptor protein called Notch-3.

The finding helped researchers to block and reverse the pathway of disease in mice.

"The UCSD team found that pulmonary hypertension is characterized by overexpression of Notch-3 and that the severity of the disease correlates with the amount of this protein in the lung. We showed that a mouse model lacking this protein does not develop pulmonary hypertension, and in addition, that the disease can be effectively treated with an enzyme called ?-secretase inhibitor, which blocks Notch-3 activation," Nature quoted Thistelthwaite as saying.

In the laboratory, mice with pulmonary arterial hypertension that were treated with the ?-secretase inhibitor showed reversal of the disease.

Forms of this drug are currently in use in Phase 1 trials for the treatment of Alzheimer's disease. Pulmonary arterial hypertension is more common in the human population than is currently realized, and unfortunately, is often fatal," said co-author Dr. Stuart Jamieson.

"Current drugs to treat pulmonary arterial hypertension focus on dilating the arterial vessels but do not address the eventual thickening of the artery walls. Fortunately, by identifying this drug target it seems we are now on the right path to developing an intervention that prevents abnormal cell proliferation," he added.

The study has been published online in Nature Medicine. (ANI)

Copyright 2009 Asian News International (ANI) - All Rights Reserved.

Provided by an company
COPYRIGHT 2009 Al Bawaba (Middle East) Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Asian News International
Date:Oct 26, 2009
Previous Article:Scientists identify master enzyme for regenerating nerve fibers in live animals.
Next Article:How carbon nanotubes can affect lining of the lungs.

Related Articles
Pulmonary Hypertension Associated With HIV Infection.
Pulmonary arterial hypertension: evaluation and management.
Sildenafil may benefit some patients with heart failure.
Blacks Waiting for Lung Transplants Face Poorer Outcomes.
Stiffening of the extrapulmonary arteries from rats in chronic hypoxic pulmonary hypertension.
Hope and courage: medical detective work helps fight Gail Bucci's pulmonary hypertension.
Expedition to Mount Everest Offers New Insights into Chronic Disease.
The value of exercise testing in the diagnosis of pulmonary arterial hypertension/ Pulmoner hipertansiyon tanisinda kardiyopulmoner egzersiz...
Pre-eclampsia may stem from misfolded proteins in urine.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters